Provided by Tiger Trade Technology Pte. Ltd.

VanEck Pharmaceutical ETF

109.44
-0.1600-0.15%
Post-market: 109.440.00000.00%19:30 EDT
Volume:128.97K
Turnover:14.12M
Market Cap:1.01B
PE:88.68
High:110.48
Open:110.00
Low:109.17
Close:109.60
52wk High:118.00
52wk Low:85.91
Shares:9.19M
Float Shares:9.19M
Volume Ratio:0.66
T/O Rate:1.40%
Dividend:2.17
Dividend Rate:1.98%
EPS(TTM):1.23
EPS(LYR):0.7765
ROE:--
ROA:--
PB:--
PE(LYR):140.94

Loading ...

Novartis Says Closely Watched Cholesterol Study Failed to Meet Goal

Dow Jones
·
Sep 05

Stocks to Watch: Ionis Pharmaceuticals, Novartis, Corvex

Dow Jones
·
Sep 05

Novartis Pelacarsen Fails Phase III Cardiovascular Outcomes Trial

MT Newswires Live
·
Sep 05

Novartis announces Phase 3 pelacarsen study did not meet primary endpoint

TIPRANKS
·
Sep 05

Novartis Says Pelacarsen Heart Disease Drug Missed Primary Endpoint

Dow Jones
·
Sep 05

Merck & Co. Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Sep 05

AbbVie Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Sep 05

Healthcare Stocks Pick up Steam as Investors Play Offense and Defense

Dow Jones
·
Sep 05

Novo Nordisk Advances New Obesity Drug NNC0721-8060 Into First Human Trial

TIPRANKS
·
Sep 05

Lilly Targets Type 1 Diabetes With New Tirzepatide Study: What Investors Should Watch

TIPRANKS
·
Sep 05

Novartis AG Falls Friday, Underperforms Market

Dow Jones
·
Sep 05

Novo Nordisk A/S Series B Stock Falls Friday, Underperforms Market

Dow Jones
·
Sep 05

Merck Price Target Raised to $170.00/Share from $150.00 by Wells Fargo

Dow Jones
·
Sep 04

Drugmakers Halt Autoimmune Trials After Deaths, Life-Threatening Side Effects

Dow Jones
·
Sep 04

Analysts Are Bullish on Top Healthcare Stocks: Annovis Bio (ANVS), AbbVie (ABBV)

TIPRANKS
·
Sep 04

Sector Update: Healthcare

MT Newswires Live
·
Sep 04

Dow Jones Top Company Headlines at 9 am ET: EQT to Buy Insurance Broker McGill in $2 Billion Deal | Tesla-Challenging ...

Dow Jones
·
Sep 04

Scotiabank Remains a Buy on AbbVie (ABBV)

TIPRANKS
·
Sep 04

Wells Fargo Adjusts Price Target on Merck & Co. to $170 From $150, Keeps Overweight Rating

MT Newswires Live
·
Sep 04

Novo Nordisk Foundation to Set Up Quantum Chip Facility

MT Newswires Live
·
Sep 04